FOXO4-DRI peptide, derived from the FOXO4 protein, targets senescent cells to induce apoptosis, potentially reversing aging effects and improving tissue homeostasis, as demonstrated in studies like those by Baar et al. It disrupts FOXO4-p53 interactions, offering promise for treating age-related diseases and enhancing outcomes in medical procedures such as autologous chondrocyte implantation.
评价